학술논문

Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.
Document Type
article
Author
Escala-Garcia, MariaCanisius, SanderKeeman, RenskeBeesley, JonathanAnton-Culver, HodaArndt, VolkerAugustinsson, AnnelieBecher, HeikoBeckmann, Matthias WBehrens, SabineBermisheva, MarinaBojesen, Stig EBolla, Manjeet KBrenner, HermannCanzian, FedericoCastelao, Jose EChang-Claude, JennyChanock, Stephen JCouch, Fergus JCzene, KamilaDaly, Mary BDennis, JoeDevilee, PeterDörk, ThiloDunning, Alison MEaston, Douglas FEkici, Arif BEliassen, A HeatherFasching, Peter AFlyger, HenrikGago-Dominguez, ManuelaGarcía-Closas, MontserratGarcía-Sáenz, José AGeisler, JürgenGiles, Graham GGrip, MerviGündert, MelanieHahnen, EricHaiman, Christopher AHåkansson, NiclasHall, PerHamann, UteHartikainen, Jaana MHeemskerk-Gerritsen, Bernadette AMHollestelle, AntoinetteHoppe, ReinerHopper, John LHunter, David JJacot, WilliamJakubowska, AnnaJohn, Esther MJung, Audrey YKaaks, RudolfKhusnutdinova, ElzaKoppert, Linetta BKraft, PeterKristensen, Vessela NKurian, Allison WLambrechts, DietherLe Marchand, LoicLindblom, AnnikaLuben, Robert NLubiński, JanMannermaa, ArtoManoochehri, MehdiMargolin, SaraMavroudis, DimitriosMuranen, Taru ANevanlinna, HeliOlshan, Andrew FOlsson, HåkanPark-Simon, Tjoung-WonPatel, Alpa VPeterlongo, PaoloPharoah, Paul DPPunie, KevinRadice, PaoloRennert, GadRennert, Hedy SRomero, AtochaRoylance, RebeccaRüdiger, ThomasRuebner, MatthiasSaloustros, EmmanouilSawyer, Elinor JSchmutzler, Rita KSchoemaker, Minouk JScott, ChristopherSouthey, Melissa CSurowy, HaraldSwerdlow, Anthony JTamimi, Rulla MTeras, Lauren RThomas, EmilieTomlinson, IanTroester, Melissa AVachon, Celine MWang, QinWinqvist, RobertWolk, Alicja
Source
Scientific reports. 11(1)
Subject
kConFab/AOCS Investigators
Cancer
Genetics
Breast Cancer
Prevention
2.1 Biological and endogenous factors
4.1 Discovery and preclinical testing of markers and technologies
Language
Abstract
Breast cancer metastasis accounts for most of the deaths from breast cancer. Identification of germline variants associated with survival in aggressive types of breast cancer may inform understanding of breast cancer progression and assist treatment. In this analysis, we studied the associations between germline variants and breast cancer survival for patients with distant metastases at primary breast cancer diagnosis. We used data from the Breast Cancer Association Consortium (BCAC) including 1062 women of European ancestry with metastatic breast cancer, 606 of whom died of breast cancer. We identified two germline variants on chromosome 1, rs138569520 and rs146023652, significantly associated with breast cancer-specific survival (P = 3.19 × 10-8 and 4.42 × 10-8). In silico analysis suggested a potential regulatory effect of the variants on the nearby target genes SDE2 and H3F3A. However, the variants showed no evidence of association in a smaller replication dataset. The validation dataset was obtained from the SNPs to Risk of Metastasis (StoRM) study and included 293 patients with metastatic primary breast cancer at diagnosis. Ultimately, larger replication studies are needed to confirm the identified associations.